What is Rosetta Genomics?
Rosetta Genomics specializes in providing critical information and resources pertaining to cancer. The company's offerings, including its blog, deliver insights into cancer treatment modalities, promote healthy living strategies, and delve into the complexities of cancer as a disease. Their primary clientele comprises individuals actively seeking knowledge and understanding regarding cancer and its comprehensive management. Rosetta Genomics aims to foster education and elevate awareness surrounding cancer-related issues, positioning itself as a key resource in the health information sector.
How much funding has Rosetta Genomics raised?
Rosetta Genomics has raised a total of $26.3M across 1 funding round:
Stock Offering
$26.3M
Stock Issuance/Offering (2007): $26.3M, investors not publicly disclosed
What's next for Rosetta Genomics?
The substantial enterprise-level capital infusion, marked by the recent strategic investment, positions Rosetta Genomics for accelerated development and expanded market reach. This financing is expected to fuel advancements in their informational resources and outreach programs, enabling the company to further its mission of educating and raising awareness about cancer. The strategic nature of this backing suggests a focus on enhancing their competitive edge and solidifying their presence within the cancer information and health awareness landscape.
See full Rosetta Genomics company page
